MedTrace Logo

Study in Unsettled Infants Experiencing Feeding Intolerance

NCT02021058 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 259

Last updated 2021-09-17

No results posted yet for this study

Summary

Multinational, multicenter, clinical trial. To evaluate the effect of an experimental formula on GI symptoms and associated behaviors in unsettled infants with parent-reported feeding intolerance

Conditions

  • Feeding Disorder

Interventions

OTHER

Experimental Formula

Experimental formula

OTHER

Standard control formula

Standard Infant formula

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Associate Professor Boosba Vivatvakin, MD · Pediatric Department, Faculty of Medicine, Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Days
Max Age
90 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-12
Primary Completion
2016-04-30
Completion
2016-08-23

Countries

  • Hong Kong
  • Philippines
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02021058 on ClinicalTrials.gov